Collaboration to Advance Immune-Targeted Drug Discovery at Baylor College of Medicine
The collaboration to develop novel small-molecule drugs allows for the fine-tuning of immune responses in multiple diseases.
Read More
The collaboration to develop novel small-molecule drugs allows for the fine-tuning of immune responses in multiple diseases.
Read MoreThe results suggest the exciting possibility of targeting this newly discovered mechanism for weight management.
Read MoreThe findings bring us one step closer to improving ER+ breast cancer patients’ response to therapy.
Read MoreThe findings open new possibilities for future treatments to prevent or treat the condition.
Read MoreDr. Felipe Andrés Piedra shares with a student from BCM Biotech Academy at Rusk his work training bacteria to eat plastic, aiding in the effort to create a cleaner, healthier world.
Read MoreThe new AI tool, called DeepMVP, significantly outperforms previously published models and has implications for the development of novel therapeutics.
Read MoreTheir findings suggest that smells play a more complex role in feeding behavior and regulation of food intake than was previously understood.
Read MoreThe findings show that diet interacts with an individual’s genetic makeup, influencing daily patterns of gene activity in the liver, especially those related to fat metabolism.
Read MoreThe findings illustrate the power of simple computational frameworks to uncover meaningful, novel disease-relevant biology that could help treat neurological conditions.
Read MoreDr. Jennifer Leonard shares with a student from BCM Biotech Academy at Ryan her work as a physician-scientist and the study of the immune system’s response to injury.
Read More